Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020848
Filing Date
2023-05-11
Accepted
2023-05-11 07:35:45
Documents
52
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bttx-20230331.htm   iXBRL 10-Q 1734328
2 EX-31.1 bttx-ex31_1.htm EX-31.1 20929
3 EX-31.2 bttx-ex31_2.htm EX-31.2 20928
4 EX-32.1 bttx-ex32_1.htm EX-32.1 12220
5 EX-32.2 bttx-ex32_2.htm EX-32.2 11683
  Complete submission text file 0000950170-23-020848.txt   5542973

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bttx-20230331_pre.xml EX-101.PRE 279102
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bttx-20230331_lab.xml EX-101.LAB 406949
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bttx-20230331_def.xml EX-101.DEF 188896
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bttx-20230331_cal.xml EX-101.CAL 35147
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bttx-20230331.xsd EX-101.SCH 46494
46 EXTRACTED XBRL INSTANCE DOCUMENT bttx-20230331_htm.xml XML 597929
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39864 | Film No.: 23908860
SIC: 8000 Services-Health Services